Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients
Published inPloS one, vol. 7, no. 6, e37983
Publication date2012
Abstract
Keywords
- CD4 Lymphocyte Count
- Drug Resistance, Viral/genetics
- Female
- HIV Infections/drug therapy/virology
- HIV Protease/genetics
- HIV Protease Inhibitors/pharmacology/therapeutic use
- Humans
- Male
- Mutation
- RNA, Viral/blood
- Viral Load
Affiliation
Research group
Citation (ISO format)
SCHERRER, Alexandra U et al. Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. In: PloS one, 2012, vol. 7, n° 6, p. e37983. doi: 10.1371/journal.pone.0037983
Main files (1)
Article (Published version)
Identifiers
- PID : unige:31692
- DOI : 10.1371/journal.pone.0037983
- PMID : 22719859
ISSN of the journal1932-6203